Telo Genomics Corp. (TSXV:TELO)

Canada flag Canada · Delayed Price · Currency is CAD
0.0400
-0.0050 (-11.11%)
At close: Feb 9, 2026
Market Cap4.02M -60.1%
Revenue (ttm)n/a
Net Income-2.71M
EPS-0.03
Shares Out100.43M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume145,000
Average Volume73,601
Open0.0400
Previous Close0.0450
Day's Range0.0400 - 0.0400
52-Week Range0.0400 - 0.1500
Beta0.04
RSI41.36
Earnings DateFeb 25, 2026

About Telo Genomics

Telo Genomics Corp., a molecular diagnostics company, engages in the development and commercialization of predictive technological products to personalize treatment plans for patients with specific conditions, primarily in Canada. The company’s TeloView platform measures the 3D structure and spatial organization of telomeres to inform on genetic and molecular characteristics that are predictive of genomic instability, identify specific disease mechanisms, predict disease risks, and determine effective treatments. Its lead product is TeloView-SM... [Read more]

Sector Healthcare
CEO Sabine Mai
Employees 6
Stock Exchange TSX Venture Exchange
Ticker Symbol TELO
Full Company Profile

Financial Performance

Financial Statements